Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study

Andrew D Blann, Amitava Banerjee, Deirdre A Lane, Christian Torp-Pedersen, Gregory Y H Lip

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

16 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftInternational Journal of Cardiology
Vol/bind201
Sider (fra-til)693-698
Antal sider6
ISSN0167-5273
DOI
StatusUdgivet - 2015

Fingeraftryk Dyk ned i forskningsemnerne om 'Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study'. Sammen danner de et unikt fingeraftryk.

  • Citationsformater